RxDoctor Payments Data

Thomas Curry, MD

Vascular Surgery · Olympia, WANPI 1811974652

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,250 of the $8,856 with a category attached, or 81.9%. 22 manufacturers reported payments, led by Medtronic at 24.4% of the total. 2025 is the largest year on record at $2,244, 4.3 times the $524 reported in 2019.

$8,856in general payments, 2019–2025

Across 231 payments — averaging $38.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Penumbra, Inc.$1K
  • W. L. Gore & Associates, Inc.$1K
  • Boston Scientific$737
  • Abiomed$731
  • Silk Road Medical, Inc.$544
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$1,60618%
  • Food & beverage$7,25082%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,856 in reported general payments places this provider in the 70th percentile of 111 vascular surgery providers in Washington.

See all vascular surgery providers in Washington

Medicare billing

Part B allowed, 2024
$151,525
Medicare patients
268
Services billed
743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium23$564
ClopidogrelClopidogrel Bisulfate41$229
Tamsulosin Hcl11$112

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →